A

Alveolus Bio

7 employees

Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2020

Funding rounds raised

Total raised

$2.5M

from 2 investors over 2 rounds

A

Alveolus Bio raised undisclosed on August 9, 2023

Investors: Innovate Alabama

A

Alveolus Bio raised $2.5M on February 15, 2023

Investors: National Heart, Lung, and Blood Institute

FAQ